DE60040678D1 - Parathyroid hormon (pth) polypeptidderivate - Google Patents

Parathyroid hormon (pth) polypeptidderivate

Info

Publication number
DE60040678D1
DE60040678D1 DE60040678T DE60040678T DE60040678D1 DE 60040678 D1 DE60040678 D1 DE 60040678D1 DE 60040678 T DE60040678 T DE 60040678T DE 60040678 T DE60040678 T DE 60040678T DE 60040678 D1 DE60040678 D1 DE 60040678D1
Authority
DE
Germany
Prior art keywords
disclosed
methods
polypeptides
pth
polypeptidderivate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60040678T
Other languages
German (de)
English (en)
Inventor
Thomas J Gardella
Henry M Kronenberg
John T Potts
Harald Jueppner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Hospital Corp
Original Assignee
General Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by General Hospital Corp filed Critical General Hospital Corp
Application granted granted Critical
Publication of DE60040678D1 publication Critical patent/DE60040678D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/635—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Obesity (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE60040678T 1999-09-29 2000-02-25 Parathyroid hormon (pth) polypeptidderivate Expired - Lifetime DE60040678D1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15692799P 1999-09-29 1999-09-29
PCT/US2000/004716 WO2001023427A1 (en) 1999-09-29 2000-02-25 Polypeptide derivatives of parathyroid hormone (pth)

Publications (1)

Publication Number Publication Date
DE60040678D1 true DE60040678D1 (en) 2008-12-11

Family

ID=22561687

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60040678T Expired - Lifetime DE60040678D1 (en) 1999-09-29 2000-02-25 Parathyroid hormon (pth) polypeptidderivate

Country Status (6)

Country Link
EP (2) EP2030986A1 (enExample)
JP (1) JP4723144B2 (enExample)
AT (1) ATE412670T1 (enExample)
DE (1) DE60040678D1 (enExample)
ES (1) ES2316354T3 (enExample)
WO (1) WO2001023427A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE458054T1 (de) 1998-11-25 2010-03-15 Gen Hospital Corp Menschliches parathyroidhormon, modifikationen, herstellung und verwendung
AU4217299A (en) 1998-11-30 2000-06-19 General Hospital Corporation, The Pth1r and pth3r receptors, methods and uses thereof
US7169567B1 (en) 1998-12-31 2007-01-30 The General Hospital Corporation Screening assay utilizing the PTH receptor
US6756480B2 (en) 2000-04-27 2004-06-29 Amgen Inc. Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
JP4837888B2 (ja) 2001-07-23 2011-12-14 ザ ジェネラル ホスピタル コーポレイション コンホメーションが拘束された副甲状腺ホルモン（ｐｔｈ）類似体
EP1592434A4 (en) * 2003-01-24 2009-07-01 Gen Hospital Corp CONFORMATION RESTRICTED PARATHORMON (PTH) ANALOGUE WITH LACTAM BRIDGES
JP5711966B2 (ja) 2007-08-01 2015-05-07 ザ ジェネラル ホスピタル コーポレイション Ｇタンパク質共役受容体および関連組成物を使用するスクリーニング方法
FR2940292B1 (fr) * 2008-12-23 2013-05-10 Isp Investments Inc Peptides derives d'hmg-coa reductase et composition cosmetique et/ou pharmaceutique les contenant
US8563513B2 (en) 2009-03-27 2013-10-22 Van Andel Research Institute Parathyroid hormone peptides and parathyroid hormone-related protein peptides and methods of use
WO2010128521A2 (en) * 2009-04-24 2010-11-11 Cadila Healthcare Limited Short-chain peptides as parathyroid hormone (pth) receptor agonist
MX358161B (es) 2010-05-13 2018-08-06 The General Hospital Corp Star Analogos de hormona paratiroidea y usos para los mismos.

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4086196A (en) * 1975-03-28 1978-04-25 Armour Pharmaceutical Company Parathyroid hormone
US4675189A (en) 1980-11-18 1987-06-23 Syntex (U.S.A.) Inc. Microencapsulation of water soluble active polypeptides
US4511502A (en) 1982-12-22 1985-04-16 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4512922A (en) 1982-12-22 1985-04-23 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4518526A (en) 1982-12-22 1985-05-21 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4620948A (en) 1982-12-22 1986-11-04 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4736866B1 (en) 1984-06-22 1988-04-12 Transgenic non-human mammals
IL78342A (en) 1985-04-04 1991-06-10 Gen Hospital Corp Pharmaceutical composition for treatment of osteoporosis in humans comprising a parathyroid hormone or a fragment thereof
US4761406A (en) 1985-06-06 1988-08-02 The Procter & Gamble Company Regimen for treating osteoporosis
WO1990009441A1 (en) 1989-02-01 1990-08-23 The General Hospital Corporation Herpes simplex virus type i expression vector
EP0945515A3 (en) 1989-11-06 2002-08-21 Cell Genesys, Inc. Production of proteins using homologous recombination
IT1238348B (it) 1989-11-16 1993-07-13 Processo per la preparazione di costrutti genetici per l'espressione del fattore di crescita nervoso in cellule eucariote.
US5266490A (en) 1991-03-28 1993-11-30 Regeneron Pharmaceuticals, Inc. Mammalian expression vector
JPH0532696A (ja) 1990-09-28 1993-02-09 Takeda Chem Ind Ltd 副甲状腺ホルモン誘導体
NZ245015A (en) 1991-11-05 1995-12-21 Transkaryotic Therapies Inc Delivery of human growth hormone through the administration of transfected cell lines encoding human growth hormone, which are physically protected from host immune response; the transfected cells and their production
US5434246A (en) * 1992-03-19 1995-07-18 Takeda Chemical Industries, Ltd. Parathyroid hormone derivatives
US5814603A (en) * 1992-06-12 1998-09-29 Affymax Technologies N.V. Compounds with PTH activity
US5589452A (en) 1992-07-14 1996-12-31 Syntex (U.S.A.) Inc. Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis
TW402639B (en) 1992-12-03 2000-08-21 Transkaryotic Therapies Inc Protein production and protein delivery
US5871486A (en) 1993-01-21 1999-02-16 Acumed, Inc. Variable pitch bone screw
ES2140359T1 (es) 1993-06-14 2000-03-01 Basf Ag Control preciso de expresion genetica en celulas eucarioticas mediante promotores que responden a la tetaciclina.
US5763416A (en) 1994-02-18 1998-06-09 The Regent Of The University Of Michigan Gene transfer into bone cells and tissues
US5656465A (en) 1994-05-04 1997-08-12 Therion Biologics Corporation Methods of in vivo gene delivery
US5714353A (en) 1994-05-24 1998-02-03 Research Corporation Technologies, Inc. Safe vectors for gene therapy
US5836905A (en) 1994-06-20 1998-11-17 Lemelson; Jerome H. Apparatus and methods for gene therapy
CA2178894A1 (en) 1995-06-15 1996-12-16 Tsunehiko Fukuda Parathyroid hormone derivatives and their use
JPH09157294A (ja) * 1995-06-15 1997-06-17 Takeda Chem Ind Ltd 副甲状腺ホルモン誘導体
US5723577A (en) * 1995-07-13 1998-03-03 Biomeasure Inc. Analogs of parathyroid hormone
US5917123A (en) 1997-03-14 1999-06-29 University Of Pittsburgh Transgenic mice containing a nucleic acid encoding tumor necrosis factor-α under the control of a cardiac specific regulatory region
ATE458054T1 (de) * 1998-11-25 2010-03-15 Gen Hospital Corp Menschliches parathyroidhormon, modifikationen, herstellung und verwendung

Also Published As

Publication number Publication date
JP4723144B2 (ja) 2011-07-13
ATE412670T1 (de) 2008-11-15
WO2001023427A1 (en) 2001-04-05
ES2316354T3 (es) 2009-04-16
EP1222208A1 (en) 2002-07-17
EP2030986A1 (en) 2009-03-04
JP2003511014A (ja) 2003-03-25
EP1222208B1 (en) 2008-10-29

Similar Documents

Publication Publication Date Title
WO2001023521A3 (en) Polypeptide derivatives of parathyroid hormone (PTH)
DE60040678D1 (en) Parathyroid hormon (pth) polypeptidderivate
IL114717A0 (en) Antibodies which activate an erythropoietin receptor
PT800519E (pt) Compostos moduladores de receptores de esteroides e metodos
IL140622A0 (en) Biphenyl sufonamide derivatives, pharmaceutical compositions containing the same and methods for the preparation thereof
ATE180479T1 (de) Sulfonat- und carbamatderivate von 3-aroyl- benzo(beta)thiophenen
IL152414A0 (en) Mammalian cytokine receptor subunit proteins, related reagents and methods
ATE304020T1 (de) Parathyroidhormon-verwandthe peptidanaloge
PT699686E (pt) Fragmentos de peptido insulinotropico do tipo glucagona biologicamente activos
IL129344A0 (en) Novel integrin receptor antagonists
ES2063278T3 (es) Proteina morfogenetica de hueso.
IL140140A0 (en) Thyroid hormone analogues and methods for their preparation
EP0965637A4 (en) Fas ANTIGEN DERIVATIVES
EP1116727A4 (en) PEPTIDE DERIVATIVE
WO1999046379A3 (en) Human receptor proteins; related reagents and methods
PT1181366E (pt) Proteínas receptoras de mamífero; reagentes e métodos relacionados
WO2000039278A8 (en) Pth functional domain conjugate peptides, derivatives thereof and novel tethered ligand-receptor molecules
ES2180550T3 (es) Moleculas receptoras de la hormona de glycoproteina.
EA200000198A1 (ru) 2-ациламинопропанамины в качестве антагонистов рецепторов тахикининов
DE69328060D1 (de) Angiotensin-II Typ-1 Rezeptor und dessen Herstellung
WO1995016709A3 (en) Anti-mullerian hormone receptor polypeptides and antibodies thereto
KR100245250B1 (en) Human follicle stimulating hormone receptor
DE69434239D1 (de) Verwendung von Progesteronrezeptor Antagonisten zur Verhütung oder Behinderung der Fertilisation
IL155687A0 (en) Polynucleotides encoding hlrrsi1 polypeptides
IT1254705B (it) Anticorpi monoclonali specifici per il fattore neuronotrofico ciliare (cntf) umano ricombinante

Legal Events

Date Code Title Description
8364 No opposition during term of opposition